title: Latent HSV 1 virus in trigeminal ganglia: the optimal site for linking prevention of Alzheimer's disease to vaccination.
authors.affiliation: Section of Neuropathology, Oregon Health Sciences University, Portland, OR, USA. ballm@ohsu.edu
authors.forename: M J
authors.initials: MJ
authors.lastname: Ball
authors.forename: R
authors.initials: R
authors.lastname: Mathews
authors.forename: I
authors.initials: I
authors.lastname: Steiner
authors.forename: J M
authors.initials: JM
authors.lastname: Hill
authors.forename: T W
authors.initials: TW
authors.lastname: Wisner
authors.forename: G H
authors.initials: GH
authors.lastname: Murdoch
authors.forename: S
authors.initials: S
authors.lastname: Kohama
authors.forename: G
authors.initials: G
authors.lastname: Sexton
authors.forename: S
authors.initials: S
authors.lastname: Nagalla
mesh_terms: D000544:Alzheimer Disease / Q000517:prevention & control* / Q000821:virology; D000818:Animals; D006561:Herpes Simplex / Q000150:complications / Q000517:prevention & control*; D018259:Herpesvirus 1, Human / Q000276:immunology*; D022283:Herpesvirus Vaccines; D006801:Humans; D014277:Trigeminal Neuralgia / Q000821:virology*
chemical_list: D022283:Herpesvirus Vaccines